13 results on '"Hardenbergh, Patricia"'
Search Results
2. Development of a standard survivorship care plan template for radiation oncologists.
- Author
-
Chen, Ronald C., Hoffman, Karen E., Sher, David J., Showalter, Timothy N., Morrell, Rosalyn, Chen, Aileen B., Benda, Rashmi, Nguyen, Paul L., Movsas, Benjamin, and Hardenbergh, Patricia
- Abstract
Purpose In response to a need expressed by members of the American Society for Radiation Oncology (ASTRO), the ASTRO Board of Directors approved an initiative to create a radiation oncology-specific survivorship care plan (SCP) template. Methods and Materials Members of the ASTRO Health Services Research Committee (which was subsequently renamed the Clinical, Translational, and Basic Science Advisory Committee) were charged with this task. Creation of the ASTRO SCP template was informed by existing SCP templates published by other organizations and modified to add radiation treatment details felt to be important by committee members. An emphasis was placed on describing diagnostic and treatment details in ways that patients and referring physicians can understand. The resulting template subsequently underwent ASTRO committee review, public comment, and was ultimately approved by the ASTRO Board of Directors. Results The standardized template includes 2 components: the first 2 pages represent an SCP that is to be given to the patient and referring physicians, whereas page 3 includes additional technical radiation therapy details which are usually included in a traditional radiation treatment summary. That is, the template serves two purposes—obviating the need for radiation oncologists to create an SCP for patients and a separate treatment completion note. Conclusions The standardized ASTRO SCP template serves an immediate need of practicing radiation oncologists to have a template that is radiation-specific and meets current requirements for SCP and radiation treatment summary. Potential future work may include development of disease-specific templates that will include more granular details regarding expected toxicities and follow-up care recommendations and working with electronic medical record system vendors to facilitate autocreation of SCP documents to reduce the burden on physicians and other staff. These future developments can make this intervention more helpful to patients, and further reduce the burden of creating SCPs. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
3. Our Lives Post-Pandemic: What Happens to Radiation Oncology After COVID-19?
- Author
-
Hardenbergh, Patricia
- Published
- 2020
- Full Text
- View/download PDF
4. Radiation-associated cardiovascular disease
- Author
-
Adams, M. Jacob, Hardenbergh, Patricia H., Constine, Louis S., and Lipshultz, Steven E.
- Subjects
- *
RADIOTHERAPY , *DRUG side effects , *HODGKIN'S disease , *BREAST cancer - Abstract
As the number of cancer survivors grows because of advances in therapy, it has become more important to understand the long-term complications of these treatments. This article presents the current knowledge of adverse cardiovascular effects of radiotherapy to the chest. Emphasis is on clinical presentations, recommendations for follow-up, and treatment of patients previously exposed to irradiation. Medline™ literature searches were performed, and abstracts related to this topic from oncology and cardiology meetings were reviewed. Potential adverse effects of mediastinal irradiation are numerous and can include coronary artery disease, pericarditis, cardiomyopathy, valvular disease and conduction abnormalities. Damage appears to be related to dose, volume and technique of chest irradiation. Effects may initially present as subclinical abnormalities on screening tests or as catastrophic clinical events. Estimates of relative risk of fatal cardiovascular events after mediastinal irradiation for Hodgkin''s disease ranges between 2.2 and 7.2 and after irradiation for left-sided breast cancer from 1.0 to 2.2. Risk is life long, and absolute risk appears to increase with length of time since exposure. Radiation-associated cardiovascular toxicity may in fact be progressive. Long-term cardiac follow-up of these patients is therefore essential, and the range of appropriate cardiac screening is discussed, although no specific, evidence-based screening regimen was found in the literature. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
5. Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.
- Author
-
Recht, Abram, Comen, Elizabeth A., Fine, Richard E., Fleming, Gini F., Hardenbergh, Patricia H., Ho, Alice Y., Hudis, Clifford A., Hwang, E. Shelley, Kirshner, Jeffrey J., Morrow, Monica, Salerno, Kilian E., JrSledge, George W., Solin, Lawrence J., Spears, Patricia A., Whelan, Timothy J., Somerfield, Mark R., and Edge, Stephen B.
- Abstract
Purpose A joint American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology panel convened to develop a focused update of the American Society of Clinical Oncology guideline concerning use of postmastectomy radiotherapy (PMRT). Methods A recent systematic literature review by Cancer Care Ontario provided the primary evidentiary basis. The joint panel also reviewed targeted literature searches to identify new, potentially practice-changing data. Recommendations The panel unanimously agreed that available evidence shows that PMRT reduces the risks of locoregional failure (LRF), any recurrence, and breast cancer mortality for patients with T1-2 breast cancer with one to three positive axillary nodes. However, some subsets of these patients are likely to have such a low risk of LRF that the absolute benefit of PMRT is outweighed by its potential toxicities. In addition, the acceptable ratio of benefit to toxicity varies among patients and physicians. Thus, the decision to recommend PMRT requires a great deal of clinical judgment. The panel agreed clinicians making such recommendations for individual patients should consider factors that may decrease the risk of LRF, attenuate the benefit of reduced breast cancer–specific mortality, and/or increase risk of complications resulting from PMRT. When clinicians and patients elect to omit axillary dissection after a positive sentinel node biopsy, the panel recommends that these patients receive PMRT only if there is already sufficient information to justify its use without needing to know additional axillary nodes are involved. Patients with axillary nodal involvement after neoadjuvant systemic therapy should receive PMRT. The panel recommends treatment generally be administered to both the internal mammary nodes and the supraclavicular-axillary apical nodes in addition to the chest wall or reconstructed breast. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
6. Utilization of a Web-Based Conferencing Platform to Improve Global Radiation Oncology Education and Quality-Proof of Principle Through Implementation in India.
- Author
-
Robin, Tyler P., Grover, Surbhi, Reddy Palkonda, Vijay Anand, Fisher, Christine M., Gehl, Brigitta, Bhattacharya, Kausik, Mallick, Indranil, Bhattasali, Onita, Viswanathan, Akila N., Sastri (Chopra), Supriya, Mahantshetty, Umesh, and Hardenbergh, Patricia H.
- Subjects
- *
RADIOTHERAPY , *ONCOLOGISTS , *RADIOISOTOPE brachytherapy , *ONCOLOGY , *MAGNETIC resonance imaging - Abstract
Purpose: Chartrounds (www.chartrounds.com) was established in the United States in 2010 as a web-based platform for radiation oncologists to review cases with leading disease-site experts. However, the need for access to experts for peer review and education is not unique to the United States, and the Chartrounds platform was therefore adapted for improved global reach. Chartrounds was first expanded to India, and herein we report our initial experience with this initiative.Methods and Materials: The US Chartrounds platform was adapted to create Chartrounds India (ind.chartrounds.com). Through collaboration with the Association of Radiation Oncologists of India, India-based specialists were recruited, and the association's membership list was used to announce sessions to potential participants.Results: Between June 2017 and January 2018, 27 Chartrounds India sessions were completed, led by 21 different specialists (representing 10 centers in India) and covering 11 different disease sites/topics. A total of 240 members from 126 centers (private: 56%; teaching: 36%; public: 8%) across 24 states/territories participated in ≥1 session. Of the 240 members who participated in ≥1 session, 159 (66%) participated in ≥2 sessions and 60 (25%) participated in ≥5 sessions. The average number of participants per session was 34 (range, 13-72). On average, 80% of respondents rated the sessions as high or very high quality; 87% and 95% agreed or strongly agreed that the time was used effectively and that the sessions were relevant to daily practice, respectively. Seventy-six percent agreed or strongly agreed that the sessions will result in a change in their practice. The average feedback survey response rate was 32% (range, 17%-49%).Conclusions: Chartrounds has proven to be an effective resource for US-based radiation oncologists, and our initial experience with Chartrounds India suggests that an online platform for radiation oncology case review and education can be successfully implemented globally with use of local disease site experts. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
7. The American Board of Radiology Initial Certification in Radiation Oncology: Moving Forward Through Collaboration.
- Author
-
Wallner, Paul E, Kachnic, Lisa A, Alektiar, Kaled M, Davis, Brian J, Hardenbergh, Patricia H, and Ng, Andrea K
- Subjects
- *
RADIOLOGY , *RADIATION , *CERTIFICATION , *ONCOLOGY , *MEDICAL specialties & specialists , *RADIOTHERAPY - Published
- 2019
- Full Text
- View/download PDF
8. Fractionation for Whole Breast Irradiation: An American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline
- Author
-
Smith, Benjamin D., Bentzen, Soren M., Correa, Candace R., Hahn, Carol A., Hardenbergh, Patricia H., Ibbott, Geoffrey S., McCormick, Beryl, McQueen, Julie R., Pierce, Lori J., Powell, Simon N., Recht, Abram, Taghian, Alphonse G., Vicini, Frank A., White, Julia R., and Haffty, Bruce G.
- Subjects
- *
MAMMOGRAMS , *ONTOLOGY , *EVIDENCE-based medicine , *BREAST cancer patients , *BREAST cancer treatment , *HEALTH outcome assessment , *CLINICAL trials , *RADIATION doses - Abstract
Purpose: In patients with early-stage breast cancer treated with breast-conserving surgery, randomized trials have found little difference in local control and survival outcomes between patients treated with conventionally fractionated (CF-) whole breast irradiation (WBI) and those receiving hypofractionated (HF)-WBI. However, it remains controversial whether these results apply to all subgroups of patients. We therefore developed an evidence-based guideline to provide direction for clinical practice. Methods and Materials: A task force authorized by the American Society for Radiation Oncology weighed evidence from a systematic literature review and produced the recommendations contained herein. Results: The majority of patients in randomized trials were aged 50 years or older, had disease Stage pT1-2 pN0, did not receive chemotherapy, and were treated with a radiation dose homogeneity within ±7% in the central axis plane. Such patients experienced equivalent outcomes with either HF-WBI or CF-WBI. Patients not meeting these criteria were relatively underrepresented, and few of the trials reported subgroup analyses. For patients not receiving a radiation boost, the task force favored a dose schedule of 42.5 Gy in 16 fractions when HF-WBI is planned. The task force also recommended that the heart should be excluded from the primary treatment fields (when HF-WBI is used) due to lingering uncertainty regarding late effects of HF-WBI on cardiac function. The task force could not agree on the appropriateness of a tumor bed boost in patients treated with HF-WBI. Conclusion: Data were sufficient to support the use of HF-WBI for patients with early-stage breast cancer who met all the aforementioned criteria. For other patients, the task force could not reach agreement either for or against the use of HF-WBI, which nevertheless should not be interpreted as a contraindication to its use. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
9. Accelerated Partial Breast Irradiation Consensus Statement from the American Society for Radiation Oncology (ASTRO)
- Author
-
Smith, Benjamin D., Arthur, Douglas W., Buchholz, Thomas A., Haffty, Bruce G., Hahn, Carol A., Hardenbergh, Patricia H., Julian, Thomas B., Marks, Lawrence B., Todor, Dorin A., Vicini, Frank A., Whelan, Timothy J., White, Julia, Wo, Jennifer Y., and Harris, Jay R.
- Published
- 2009
- Full Text
- View/download PDF
10. Impact of patient-specific factors, irradiated left ventricular volume, and treatment set-up errors on the development of myocardial perfusion defects after radiation therapy for left-sided breast cancer
- Author
-
Evans, Elizabeth S., Prosnitz, Robert G., Yu, Xiaoli, Zhou, Su-Min, Hollis, Donna R., Wong, Terence Z., Light, Kim L., Hardenbergh, Patricia H., Blazing, Michael A., and Marks, Lawrence B.
- Subjects
- *
CANCER treatment , *BREAST cancer , *CANCER patients , *RADIOTHERAPY - Abstract
Purpose: The aim of this study was to assess the impact of patient-specific factors, left ventricle (LV) volume, and treatment set-up errors on the rate of perfusion defects 6 to 60 months post–radiation therapy (RT) in patients receiving tangential RT for left-sided breast cancer. Methods and Materials: Between 1998 and 2005, a total of 153 patients were enrolled onto an institutional review board–approved prospective study and had pre- and serial post-RT (6–60 months) cardiac perfusion scans to assess for perfusion defects. Of the patients, 108 had normal pre-RT perfusion scans and available follow-up data. The impact of patient-specific factors on the rate of perfusion defects was assessed at various time points using univariate and multivariate analysis. The impact of set-up errors on the rate of perfusion defects was also analyzed using a one-tailed Fisher’s Exact test. Results: Consistent with our prior results, the volume of LV in the RT field was the most significant predictor of perfusion defects on both univariate (p = 0.0005 to 0.0058) and multivariate analysis (p = 0.0026 to 0.0029). Body mass index (BMI) was the only significant patient-specific factor on both univariate (p = 0.0005 to 0.022) and multivariate analysis (p = 0.0091 to 0.05). In patients with very small volumes of LV in the planned RT fields, the rate of perfusion defects was significantly higher when the fields set-up “too deep” (83% vs. 30%, p = 0.059). The frequency of deep set-up errors was significantly higher among patients with BMI ≥25 kg/m2 compared with patients of normal weight (47% vs. 28%, p = 0.068). Conclusions: BMI ≥25 kg/m2 may be a significant risk factor for cardiac toxicity after RT for left-sided breast cancer, possibly because of more frequent deep set-up errors resulting in the inclusion of additional heart in the RT fields. Further study is necessary to better understand the impact of patient-specific factors and set-up errors on the development of RT-induced perfusion defects. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
11. The incidence and functional consequences of RT-associated cardiac perfusion defects
- Author
-
Marks, Lawrence B., Yu, Xiaoli, Prosnitz, Robert G., Zhou, Su-Min, Hardenbergh, Patricia H., Blazing, Michael, Hollis, Donna, Lind, Pehr, Tisch, Andrea, Wong, Terence Z., and Borges-Neto, Salvador
- Subjects
- *
RADIOTHERAPY , *BREAST cancer , *PERFUSION , *HEMOPERFUSION , *BREAST tumors , *COMPARATIVE studies , *CORONARY circulation , *HEART , *CARDIAC contraction , *LONGITUDINAL method , *RESEARCH methodology , *MEDICAL cooperation , *RADIATION doses , *RADIATION injuries , *RESEARCH , *EVALUATION research , *SINGLE-photon emission computed tomography , *STROKE volume (Cardiac output) , *PHYSIOLOGICAL effects of radiation , *PHYSIOLOGY - Abstract
Purpose: Radiation therapy (RT) for left-sided breast cancer has been associated with cardiac dysfunction. We herein assess the temporal nature and volume dependence of RT-induced left ventricular perfusion defects and whether these perfusion defects are related to changes in cardiac wall motion or alterations in ejection fraction.Methods: From 1998 to 2001, 114 patients were enrolled onto an IRB-approved prospective clinical study to assess changes in regional and global cardiac function after RT for left-sided breast cancer. Patients were imaged 30 to 60 minutes after injection of technetium 99m sestamibi or tetrofosmin. Post-RT perfusion scans were compared with the pre-RT studies to assess for RT-induced perfusion defects as well as functional changes in wall motion and ejection fraction. Two-tailed Fisher's exact test and the Cochran-Armitage test for linear trends were used for statistical analysis.Results: The incidence of new perfusion defects 6, 12, 18, and 24 months after RT was 27%, 29%, 38%, and 42%, respectively. New defects occurred in approximately 10% to 20% and 50% to 60% of patients with less than 5%, and greater than 5%, of their left ventricle included within the RT fields, respectively (p = 0.33 to 0.00008). The rates of wall motion abnormalities in patients with and without perfusion defects were 12% to 40% versus 0% to 9%, respectively; p values were 0.007 to 0.16, depending on the post-RT interval.Conclusions: Radiation therapy causes volume-dependent perfusion defects in approximately 40% of patients within 2 years of RT. These perfusion defects are associated with corresponding wall-motion abnormalities. Additional study is necessary to better define the long-term functional consequences of RT-induced perfusion defects. [ABSTRACT FROM AUTHOR]- Published
- 2005
- Full Text
- View/download PDF
12. Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution
- Author
-
Lind, Pehr A., Pagnanelli, Robert, Marks, Lawrence B., Borges-Neto, Salvador, Hu, Caroline, Zhou, Su-Min, Light, Kim, and Hardenbergh, Patricia H.
- Subjects
- *
BREAST cancer , *RADIOTHERAPY - Abstract
Purpose: To evaluate postradiation regional heart perfusion changes with single photon emission tomography (SPECT) myocardial perfusion imaging in 69 patients treated with tangential photon beams radiation therapy (RT) for left-sided breast cancer. To correlate SPECT changes with percent irradiated left ventricle (LV) volume and risk factors for coronary artery disease (CAD).Methods and Materials: Rest SPECT of the LV was acquired pre-RT and at 6-month intervals post-RT. The extent of defects (%) with a severity > 1.5 standard deviations below the mean was quantitatively analyzed for the distributions of the left anterior descending (LAD) artery, left circumflex (LCX) artery, and right coronary artery (RCA) based on computer assisted polar map reconstruction (i.e., bull’s-eye-view). Changes in perfusion were correlated with percent irradiated LV receiving > 25 Gy (range 0–32%). Data on patient- and treatment-related factors were collected prospectively (e.g., cardiac premorbidity, risk factors for CAD, chemotherapy, and hormonal treatment).Results: In the LAD distribution, there were increased perfusion defects at 6 months (median 11%; interquartile range 2–23) compared with baseline (median 5%; interquartile range 1–14) (p < 0.001). There were no increases in perfusion defects in the LCX or RCA distributions. In multivariate analysis, the SPECT perfusion changes in the LAD distribution at 6 months were independently associated with percent irradiated LV (p < 0.001), hormonal therapy (p = 0.005), and pre-RT hypercholesterolemia (p = 0.006). The SPECT defects in the LAD distribution at 12 and 18 months were not statistically different from those at 6 months. The perfusion defects in the LAD distribution were limited essentially to the regions of irradiated myocardium.Conclusion: Tangential photon beam RT in patients with left-sided breast cancer was associated with short-term SPECT defects in the vascular distribution corresponding to the radiation portals. Factors related to the extent of perfusion defects included the percent irradiated LV, hormonal treatment, and pre-RT hypercholesterolemia. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
13. In Reply to Dr. Beal et al
- Author
-
Smith, Benjamin D., Arthur, Douglas W., Todor, Dorin A., Buchholz, Thomas A., Haffty, Bruce G., Hahn, Carol A., Hardenbergh, Patricia H., Julian, Thomas B., Marks, Lawrence B., Vicini, Frank A., Whelan, Timothy J., White, Julia, Wo, Jennifer Y., and Harris, Jay R.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.